|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 33816 |
FusionGeneSummary for SHROOM3_FABP5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SHROOM3_FABP5 | Fusion gene ID: 33816 | Hgene | Tgene | Gene symbol | SHROOM3 | FABP5 | Gene ID | 57619 | 2171 |
| Gene name | shroom family member 3 | fatty acid binding protein 5 | |
| Synonyms | APXL3|MSTP013|SHRM|ShrmL | E-FABP|EFABP|KFABP|PA-FABP|PAFABP | |
| Cytomap | 4q21.1 | 8q21.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein Shroom3F-actin-binding proteinshroom-related protein | fatty acid-binding protein, epidermalepidermal-type fatty acid-binding proteinfatty acid binding protein 5 (psoriasis-associated)psoriasis-associated fatty acid-binding protein homolog | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q8TF72 | Q01469 | |
| Ensembl transtripts involved in fusion gene | ENST00000296043, ENST00000473602, | ENST00000297258, ENST00000396359, | |
| Fusion gene scores | * DoF score | 15 X 11 X 9=1485 | 1 X 1 X 1=1 |
| # samples | 17 | 1 | |
| ** MAII score | log2(17/1485*10)=-3.12685627955043 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: SHROOM3 [Title/Abstract] AND FABP5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-A8-A09X-01A | SHROOM3 | chr4 | 77701799 | + | FABP5 | chr8 | 82192771 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-5UTR | ENST00000296043 | ENST00000297258 | SHROOM3 | chr4 | 77701799 | + | FABP5 | chr8 | 82192771 | + |
| 3UTR-intron | ENST00000296043 | ENST00000396359 | SHROOM3 | chr4 | 77701799 | + | FABP5 | chr8 | 82192771 | + |
| intron-5UTR | ENST00000473602 | ENST00000297258 | SHROOM3 | chr4 | 77701799 | + | FABP5 | chr8 | 82192771 | + |
| intron-intron | ENST00000473602 | ENST00000396359 | SHROOM3 | chr4 | 77701799 | + | FABP5 | chr8 | 82192771 | + |
Top |
FusionProtFeatures for SHROOM3_FABP5 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SHROOM3 | FABP5 |
| Controls cell shape changes in the neuroepitheliumduring neural tube closure. Induces apical constriction inepithelial cells by promoting the apical accumulation of F-actinand myosin II, and probably by bundling stress fibers. Inducesapicobasal cell elongation by redistributing gamma-tubulin anddirecting the assembly of robust apicobasal microtubule arrays (Bysimilarity). {ECO:0000250}. | Intracellular carrier for long-chain fatty acids andrelated active lipids, such as the endocannabinoid, that regulatesthe metabolism and actions of the ligands they bind. In additionto the cytosolic transport, selectively delivers specific fattyacids from the cytosol to the nucleus, wherein they activatenuclear receptors (PubMed:22170058). Delivers retinoic acid to thenuclear receptor peroxisome proliferator-activated receptor delta;which promotes proliferation and survival. May also serve as asynaptic carrier of endocannabinoid at central synapses and thuscontrols retrograde endocannabinoid signaling. Modulatesinflammation by regulating PTGES induction via NF-kappa-Bactivation, and prostaglandin E2 (PGE2) biosynthesis duringinflammation (By similarity). May be involved in keratinocytedifferentiation (PubMed:8092987). {ECO:0000250|UniProtKB:Q05816,ECO:0000269|PubMed:22170058, ECO:0000269|PubMed:8092987}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SHROOM3_FABP5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SHROOM3_FABP5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SHROOM3 | SFN, SAAL1, YWHAB, UBTD1, CDK2, ILK, RPS6KA2, SIK2, RPS6KB2, MYH9, RAB32, SNW1, CDC5L, CDH1, TRIM25 | FABP5 | STK24, S100A7, PPP2R2A, CEP57, TUBGCP3, EZH2, CCDC51, AKR1B1, ECI1, ALDOA, ALDOC, ATP5J, ENO1, ENO2, ENO3, EZR, GLO1, HINT1, HSD17B10, MSN, PGAM1, PGD, RDX, SOD1, STIP1, TAGLN, TAGLN2, TAGLN3, TKT, FKBP1A, FKBP1B, GRB2, HSPE1, PIN1, MCM2, PCGF1, POU5F1, U2AF2, RBM3, CYLD |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SHROOM3_FABP5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SHROOM3_FABP5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | FABP5 | C0036341 | Schizophrenia | 2 | PSYGENET |
| Tgene | FABP5 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
| Tgene | FABP5 | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|